> top > docs > PubMed:2156607 > annotations

PubMed:2156607 JSONTXT

Annnotations TAB JSON ListView MergeView

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 541-546 HP_0002664 denotes tumor
T2 622-627 HP_0002664 denotes tumor
T3 1014-1020 HP_0002664 denotes tumors
T4 1391-1397 HP_0002664 denotes tumors

jnlpba-st-training

Id Subject Object Predicate Lexical cue
T1 583-600 protein denotes estrogen receptor

pubmed-sentences-benchmark

Id Subject Object Predicate Lexical cue
S1 0-132 Sentence denotes Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy.
S2 133-331 Sentence denotes Risk factors for local failure were evaluated for 496 clinical Stage I-II patients with infiltrating ductal carcinomas (median follow-up, 71 months) treated by conservative surgery and radiotherapy.
S3 332-683 Sentence denotes Monofactorial analysis identified the following factors to be correlated with increased risk: moderate/marked mononuclear cell reaction (MCR), high histologic grade (G), extensive intraductal component (EIC), tumor necrosis, macroscopic multiplicity, estrogen receptor negativity, anatomic tumor size, age younger than 40 years, and vascular invasion.
S4 684-753 Sentence denotes Only MCR, G, and EIC proved significant in Cox multivariate analysis.
S5 754-894 Sentence denotes These risk factors were highly age dependent, with EIC markedly more prevalent in women younger than 50, MCR and G in women younger than 40.
S6 895-1104 Sentence denotes Separate Cox analysis for premenopausal patients showed that MCR/EIC determined risk independent of resection margins: tumors with MCR had a 28%, and with EIC a 22% probability of recurring locally by 5 years.
S7 1105-1218 Sentence denotes Premenopausal patients with neither risk factor had a very low failure rate (2.6% at 5 years), regardless of age.
S8 1219-1454 Sentence denotes For postmenopausal patients risk of breast recurrence was determined both by adequacy of resection margins and grade, with a high local failure rate for patients having G3 tumors with positive or indeterminate margins (31% at 5 years).
S9 1455-1655 Sentence denotes The authors conclude that the microscopic examination is the only useful tool for assessing the risk of local failure, which is quite low for the majority of patients treated with breast conservation.
S10 1656-1709 Sentence denotes High-risk patients can be recognized morphologically.
S11 1710-1837 Sentence denotes The age dependence of morphologic risk factors appears to explain the high local failure rate seen in patients younger than 40.

genia-medco-coref

Id Subject Object Predicate Lexical cue
C2 17-34 NP denotes breast recurrence
C3 38-131 NP denotes premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy
C1 0-131 NP denotes Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy
C5 150-163 NP denotes local failure
C4 133-163 NP denotes Risk factors for local failure
C6 183-330 NP denotes 496 clinical Stage I-II patients with infiltrating ductal carcinomas (median follow-up, 71 months) treated by conservative surgery and radiotherapy
C7 366-387 NP denotes the following factors
C9 426-473 NP denotes moderate/marked mononuclear cell reaction (MCR)
C10 475-500 NP denotes high histologic grade (G)
C11 502-539 NP denotes extensive intraductal component (EIC)
C8 426-682 NP denotes moderate/marked mononuclear cell reaction (MCR), high histologic grade (G), extensive intraductal component (EIC), tumor necrosis, macroscopic multiplicity, estrogen receptor negativity, anatomic tumor size, age younger than 40 years, and vascular invasion
C13 689-692 NP denotes MCR
C14 694-695 NP denotes G
C15 701-704 NP denotes EIC
C12 689-704 NP denotes MCR, G, and EIC
C16 754-772 NP denotes These risk factors
C17 805-808 NP denotes EIC
C18 859-862 NP denotes MCR
C19 867-868 NP denotes G
C20 995-1012 NP denotes resection margins
C21 1026-1029 NP denotes MCR
C22 1050-1053 NP denotes EIC
C24 1255-1272 NP denotes breast recurrence
C23 1247-1272 NP denotes risk of breast recurrence
C25 1308-1325 NP denotes resection margins
C27 1559-1572 NP denotes local failure
C26 1547-1572 NP denotes the risk of local failure
C28 1574-1579 NP denotes which
C29 1732-1756 NP denotes morphologic risk factors
R1 C5 C2 coref-ident local failure,breast recurrence
R2 C4 C1 coref-ident Risk factors for local failure,Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy
R3 C6 C3 coref-ident "496 clinical Stage I-II patients with infiltrating ductal carcinomas (median follow-up, 71 months) treated by conservative surgery and radiotherapy",premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy
R4 C7 C4 coref-ident the following factors,Risk factors for local failure
R5 C8 C7 coref-ident "moderate/marked mononuclear cell reaction (MCR), high histologic grade (G), extensive intraductal component (EIC), tumor necrosis, macroscopic multiplicity, estrogen receptor negativity, anatomic tumor size, age younger than 40 years, and vascular invasion",the following factors
R6 C13 C9 coref-ident MCR,moderate/marked mononuclear cell reaction (MCR)
R7 C14 C10 coref-ident G,high histologic grade (G)
R8 C15 C11 coref-ident EIC,extensive intraductal component (EIC)
R9 C16 C12 coref-ident These risk factors,"MCR, G, and EIC"
R10 C17 C15 coref-ident EIC,EIC
R11 C18 C13 coref-ident MCR,MCR
R12 C19 C14 coref-ident G,G
R13 C21 C18 coref-ident MCR,MCR
R14 C22 C17 coref-ident EIC,EIC
R15 C24 C5 coref-ident breast recurrence,local failure
R16 C25 C20 coref-ident resection margins,resection margins
R17 C27 C24 coref-ident local failure,breast recurrence
R18 C26 C23 coref-ident the risk of local failure,risk of breast recurrence
R19 C28 C26 coref-relat which,the risk of local failure
R20 C29 C16 coref-ident morphologic risk factors,These risk factors

GENIAcorpus

Id Subject Object Predicate Lexical cue
T1 85-99 other_name denotes ductal cancers
T2 111-131 other_name denotes conservation therapy
T3 187-206 multi_cell denotes clinical Stage I-II
T4 207-215 multi_cell denotes patients
T5 221-251 other_name denotes infiltrating ductal carcinomas
T6 293-313 other_name denotes conservative surgery
T7 318-330 other_name denotes radiotherapy
T8 332-354 other_name denotes Monofactorial analysis
T9 442-467 other_name denotes mononuclear cell reaction
T10 469-472 other_name denotes MCR
T11 475-496 other_name denotes high histologic grade
T12 502-533 other_name denotes extensive intraductal component
T13 535-538 other_name denotes EIC
T14 541-555 other_name denotes tumor necrosis
T15 557-581 other_name denotes macroscopic multiplicity
T16 583-600 protein_family_or_group denotes estrogen receptor
T17 613-632 other_name denotes anatomic tumor size
T18 665-682 other_name denotes vascular invasion
T19 689-692 other_name denotes MCR
T20 694-695 other_name denotes G
T21 701-704 other_name denotes EIC
T22 727-752 other_name denotes Cox multivariate analysis
T23 805-808 other_name denotes EIC
T24 836-841 multi_cell denotes women
T25 859-862 other_name denotes MCR
T26 872-877 multi_cell denotes women
T27 904-916 multi_cell denotes Cox analysis
T28 921-934 multi_cell denotes premenopausal
T29 935-943 multi_cell denotes patients
T30 956-959 other_name denotes MCR
T31 959-963 other_name denotes /EIC
T32 1014-1020 tissue denotes tumors
T33 1026-1029 other_name denotes MCR
T34 1050-1053 other_name denotes EIC
T35 1105-1118 multi_cell denotes Premenopausal
T36 1119-1127 multi_cell denotes patients
T37 1223-1237 multi_cell denotes postmenopausal
T38 1238-1246 multi_cell denotes patients
T39 1372-1380 multi_cell denotes patients
T40 1388-1397 tissue denotes G3 tumors
T41 1485-1508 other_name denotes microscopic examination
T42 1613-1621 multi_cell denotes patients
T43 1635-1654 other_name denotes breast conservation
T44 1666-1674 multi_cell denotes patients
T45 1732-1756 other_name denotes morphologic risk factors
T46 1812-1820 multi_cell denotes patients